Ozone therapy in chronic viral hepatitis C in third age patients
DOI:
https://doi.org/10.7203/jo3t.6.7.2022.25982Resum
Chronic viral hepatitis C (HCV) is a global medical problem, its prevalence increases with age and involves high morbidity and mortality in the elderly population. The disease progresses slowly and is detected, accidentally, leading to devitalization of the body and it’s difficult to treat. In most cases, hepatitis C leads to complications such as cirrhosis (20-25%), ascites, liver carcinoma (5%), hepatocellular failure. The usual line of treatment is expensive, involves major side effects and low efficiency, high number of comorbidities, polypragmatism makes the difference for the elderly with the need to individualize treatment. Overlapping pathological changes with age-dependent ones determine the clinical picture with decreased physical activity and loss of functionality. The present study aimed to update HCV treatment regimens in the elderly by including ozone therapy, evaluating clinical, para clinical and functional efficacy.Descàrregues
Descàrregues
Publicades
Com citar
-
Resum233
-
PDF 162
Número
Secció
Llicència
Journal of Ozone Therapy applies the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC 4.0) license to works we publish.
Under this license, authors retain ownership of the copyright for their content, but allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. No permission is required from the authors or the publishers.
You may not use the material for commercial purposes.
Appropriate attribution can be provided by simply citing the original article, provide a link to the license, and indicate if changes were made.
You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.